% | $
Quotes you view appear here for quick access.

Optimer Pharmaceuticals, AŞ Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • eastcoasttroll eastcoasttroll Jan 8, 2013 1:34 PM Flag

    Take-over target, finally?


    Regarding Cubist ... the $2.8 billion company, with at least three new therapies in the pipeline, still will need to use its $897 million in cash to buy a drugmaker such as Optimer Pharmaceuticals Inc. or Cadence Pharmaceuticals Inc., said Robert W. Baird & Co. A takeover of either would top Cubist’s largest deals for Calixa Therapeutics Inc. and Adolor Corp., data compiled by Bloomberg show. Cantor Fitzgerald LP says it also could look to smaller targets Trius Therapeutics Inc. or Cempra Inc. to add to its antibiotics portfolio.

    This topic is deleted.